Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis.

Abstract

BACKGROUND Methotrexate (MTX) is among the most effective disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA) with less toxicity and better tolerability. OBJECTIVES To evaluate the efficacy and toxicity of MTX monotherapy compared to MTX combination with non-biologic DMARDs in adult with RA. SEARCH STRATEGY Trials were… (More)
DOI: 10.1002/14651858.CD008495

Topics

1 Figure or Table

Cite this paper

@article{Katchamart2010MethotrexateMV, title={Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis.}, author={Wanruchada Katchamart and Judith Trudeau and Veerapong Phumethum and Claire Bombardier}, journal={The Cochrane database of systematic reviews}, year={2010}, volume={4}, pages={CD008495} }